Cargando…
The Performance of GALAD Score for Diagnosing Hepatocellular Carcinoma in Patients with Chronic Liver Diseases: A Systematic Review and Meta-Analysis
Background GALAD score, comprising five clinical parameters, is a predictive model developed for hepatocellular carcinoma (HCC) detection. Since its emergence, its diagnostic ability has been validated in different populations with a wide variation. Therefore, we conducted a meta-analysis to investi...
Autores principales: | Guan, Ming-Cheng, Zhang, Shi-Yu, Ding, Qian, Li, Na, Fu, Ting-Ting, Zhang, Gui-Xia, He, Qian-Qian, Shen, Feng, Yang, Tian, Zhu, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918029/ https://www.ncbi.nlm.nih.gov/pubmed/36769597 http://dx.doi.org/10.3390/jcm12030949 |
Ejemplares similares
-
Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma
por: Cagnin, Silvia, et al.
Publicado: (2023) -
ASAP Score versus GALAD Score for detection of hepatitis C-related hepatocellular carcinoma: A multicenter case-control analysis
por: Liu, Si-Yu, et al.
Publicado: (2022) -
Evaluation of GALAD Score in Diagnosis and Follow-up of Hepatocellular Carcinoma after Local Ablative Therapy
por: Eletreby, Rasha, et al.
Publicado: (2023) -
GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients
por: Schotten, Clemens, et al.
Publicado: (2021) -
Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients
por: Liu, Miaoxia, et al.
Publicado: (2020)